Mantle Bio

Mantle Bio

Private
Cambridge, MassachusettsHealthcare & Life Scienceshttp://www.mantlebio.com

Last Round

Seed

Jul 11, 2023

Total Funding Raised

$5M

Company Overview

Mantle Bio is a drug discovery company developing a platform to create the next generation of medicines by stabilizing protein function. Founded in 2021 by scientists from the Whitehead Institute for Biomedical Research, the company combines high-throughput multiplexed screening and computational methods to develop biologics. It is a privately held biotechnology firm based in Cambridge, Massachusetts.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Vertical SaaS, Data Integration, Low-Code/No-Code, Database Management

Business Model

B2B

Customer Profile

Freemium, Subscription SaaS, Services & Consulting

AI Layer

Non-AI

Keywords

life science data platformbioinformatics platformdry lab softwarecomputational biology platformmulti-omics data analysisbiological data managementlab informaticsreproducible researchdata engineering platformbiological data lakeno-code data analysisJupyter notebooksPython SDKELN integrationfreemium SaaS

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Mantle Bio Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Mantle Bio Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
SeedJul 11, 2023

Mantle Bio Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 21, 2025

    Added TypeForm, a technology/SaaS company, as a customer.

Mantle Bio Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Mantle Bio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Mantle Bio's valuation, stock price, and market status.

Firmographic Details

HeadquartersCambridge, Massachusetts
Employee Range-
Year Founded2021
Last FundingJul 11, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.